EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Antihypertensive Effects of Lindera erythrocarpa Makino via NO/cGMP Pathway and Ca2+ and K+ Channels

Sujin Shin iD, Junkyu Park iD, Ho-Young Choi iD, Youngmin Bu, Kyungjin Lee iD

Nutrients · 2024

DOI: 10.3390/nu16173003 ↗

At a glance

Journal article in Nutrients, 2024. Written by Sujin Shin and 4 co-authors. Institution: Department of Korean Medicine, Graduate School, Kyung Hee University, Seoul 02447, Republic of Korea. Major MEDLINE topics: Antihypertensive Agents, Plant Extracts, Nitric Oxide, Rats, Sprague-Dawley. Cited 1 times so far (Crossref); 40 references. The full text is freely available (open access, CC BY 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Studies have demonstrated the therapeutic effects of Lindera plants. This study was undertaken to reveal the antihypertensive properties of Lindera erythrocarpa leaf ethanolic extract (LEL). Aorta segments of Sprague–Dawley rats were used to study the vasodilatory effect of LEL, and the mechanisms involved were evaluated by treating specific inhibitors or activators that affect the contractility of blood vessels. Our results revealed that LEL promotes a vasorelaxant effect through the nitric oxide/cyclic guanosine 3′,5′-monophosphate pathway, blocking the Ca2+ channels, opening the K+ channels, and inhibiting the vasoconstrictive action of angiotensin II. In addition, the effects of LEL on blood pressure were investigated in spontaneously hypertensive rats by the tail-cuff method. LEL (300 or 1000 mg/kg) was orally administered to the rats, and 1000 mg/kg of LEL significantly lowered the blood pressure. Systolic blood pressure decreased by −20.06 ± 4.87%, and diastolic blood pressure also lowered by −30.58 ± 5.92% at 4 h in the 1000 mg/kg LEL group. Overall, our results suggest that LEL may be useful to treat hypertensive diseases, considering its vasorelaxing and hypotensive effects.

Subjects

MeSH terms (MEDLINE)

Antihypertensive AgentsPlant ExtractsNitric OxideRats, Sprague-DawleyBlood PressureCyclic GMPRats, Inbred SHRHypertensionLinderaAnimalsMaleRatsPotassium ChannelsCalcium ChannelsPlant LeavesVasodilationSignal TransductionVasodilator Agents

Author keywords

Lindera erythrocarpaNO/cGMP pathwayangiotensin IIblood pressureendotheliumhypertensionhypotensive effectspontaneously hypertensive ratvasorelaxant

Substances

Antihypertensive AgentsPlant ExtractsNitric OxideCyclic GMPPotassium ChannelsCalcium ChannelsVasodilator Agents

Authors and institutions

  • Department of Korean Medicine, Graduate School, Kyung Hee University, Seoul 02447, Republic of Korea.
  • Department of Science in Korean Medicine, Graduate School, Kyung Hee University, Seoul 02447, Republic of Korea.
  • Department of Herbal Pharmacology, College of Korean Medicine, Kyung Hee University, Seoul 02447, Republic of Korea.

ORCID profiles: Sujin Shin, Junkyu Park, Ho-Young Choi, Kyungjin Lee

Cite

APA

Shin, S., Park, J., Choi, H. Y., Bu, Y., & Lee, K. (2024). Antihypertensive Effects of Lindera erythrocarpa Makino via NO/cGMP Pathway and Ca2+ and K+ Channels. Nutrients. https://doi.org/10.3390/nu16173003

Vancouver

Shin S, Park J, Choi HY, Bu Y, Lee K. Antihypertensive Effects of Lindera erythrocarpa Makino via NO/cGMP Pathway and Ca2+ and K+ Channels. Nutrients. 2024. doi:10.3390/nu16173003

BibTeX
@article{Shin2024,
  author = {Shin, Sujin and Park, Junkyu and Choi, Ho-Young and Bu, Youngmin and Lee, Kyungjin},
  title = {Antihypertensive Effects of Lindera erythrocarpa Makino via NO/cGMP Pathway and Ca2+ and K+ Channels},
  journal = {Nutrients},
  year = {2024},
  doi = {10.3390/nu16173003}
}
Start for free →